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Introduction {#sec1}
============

In South Korea, the largest cluster of cases related to the religious group Shincheonji was recognized in Daegu city from 12 February 2020 \[[@bib1]\]. Korean epidemiological teams meticulously sought out the close contacts of this religious group and performed extensive laboratory tests for SARS-CoV-2 in all the identified close contacts. As a result, 3081 cases of coronavirus disease 2019 (COVID-19) were confirmed in Daegu city alone as of 2 March 2020, approximately 70% of whom were related to this religious group \[[@bib1]\].

As a result of the sharp increase in the number of patients with COVID-19 in Daegu, the Korean government decided to admit those without moderate-to-severe illness or risk factors for poor prognosis to a non-hospital facility for isolation and monitoring. This policy provided a unique chance to assess the prevalence of asymptomatic individuals in this outbreak and to characterize the symptoms of people with mild COVID-19.

Methods {#sec2}
=======

As of 2 March 2020, a total of 19 636 diagnostic tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had been performed in the Daegu area \[[@bib2]\]. Of these tests, 12 947 (66%) were performed in the general population in Daegu city and 6689 (34%) were performed in those related to the Shincheonji church; of the latter, about 60% had positive results \[[@bib2]\]. As such, a total of 3081 individuals were diagnosed in the Daegu area, almost 70% (2136/3081) of whom were related to the religious group \[[@bib2]\]. These 3081 individuals with confirmed COVID-19 were isolated in hospitals and community isolation facilities, depending on their risk assessment. Among 17 community isolation facilities, our facility housed 260 individuals. The Korean government and Daegu local government allocated individuals with mild COVID-19 to dedicated isolation facilities and the remaining individuals with moderate-to-severe COVID-19 (early warning score for SARS-CoV-2 infection patients ≥4) or those with high risk to hospitals \[[@bib3]\]. The high-risk factors for COVID-19 were as follows: (a) ≥65 years, (b) chronic underlying diseases (e.g. diabetes mellitus, chronic renal failure, chronic liver disease, chronic lung disease, chronic cardiovascular disease), (c) haematological malignancy, and (d) those receiving chemotherapy or immunosuppressive agents. Regardless of their symptoms, all confirmed patients were isolated in hospitals or isolation facilities according to their risk assessment.

We conducted a questionnaire survey from 12 to 16 March 2020 in a community facility designated for the isolation of individuals with COVID-19; this facility is located approximately 50 miles from Daegu city. Diagnosis of COVID-19 was based on the results of real-time RT-PCR (Allplex 2019-nCoV Assay kit; Seegene, Seoul, South Korea), for SARS-CoV-2 E gene, RdRp gene and N gene using nasopharyngeal swab samples as authorized by the Korean government. Written informed consent was obtained from each participant who agreed to participate in this questionnaire study. Missing data were acquired with telephone interviews by trained doctors. The study protocol was approved by the Institutional Review Board of Asan Medical Centre (Seoul, Korea).

Results {#sec3}
=======

Of the 260 PCR-confirmed individuals with COVID-19, 213 (81.9%) participated in this study. Of them, 41 (19.2%, 95% CI 14.5%--25.1%) had remained asymptomatic until admission.

In the remaining 172 individuals, the median duration from the first symptom to laboratory confirmation was 14 days (interquartile range 8--17), and the median duration from laboratory confirmation to admission was 3 days (interquartile range 3--6). Cough (40.1%; 69/172) was the most common symptom, followed by sputum (39.5%; 68/172), hyposmia (39.5%; 68/172), and nasal congestion (34.3%; 59/172). Of the 68 individuals with hyposmia, 61 (90%) had accompanying symptoms such as hypogeusia, nasal congestion or rhinorrhea. Fever (\>37.5°C) was noted in only 20 (11.6%) individuals. The detailed clinical characteristics of the symptomatic patients are shown in [Table 1](#tbl1){ref-type="table"} (and see [Supplementary material, Fig. S1](#appsec1){ref-type="sec"}), and [Table S1 (see Supplementary material)](#appsec1){ref-type="sec"} shows the distribution of the symptoms according to different time-points (i.e. symptom onset, at diagnosis, at admission).Table 1Clinical presentation of the 172 symptomatic individuals with mild COVID-19[a](#tbl1fna){ref-type="table-fn"}Table 1*n* (%)Age, median (IQR), years26 (22--47)Male sex66 (38.4)Fever (\>37.5°C)20 (11.6)Cough69 (40.1)Sputum68 (39.5)Hyposmia[b](#tbl1fnb){ref-type="table-fn"}68 (39.5)Nasal congestion59 (34.3)Hypogeusia58 (33.7)Myalgia54 (31.4)Headache54 (31.4)Fatigue46 (26.7)Rhinorrhoea45 (26.2)Dizziness32 (18.6)Chills31 (18.0)Sore throat31 (18.0)Diarrhoea27 (15.7)Anorexia23 (13.4)Dyspnoea7 (4.1)Nausea7 (4.1)Abdominal pain5 (2.9)Pleuritic chest pain3 (1.7)Vomiting2 (1.2)Haemoptysis1 (0.6)Time from initial symptoms to diagnosis, median (IQR), days14 (8--17)Time from diagnosis to admission, median (IQR), days3 (3--6)[^2][^3][^4]

Discussion {#sec4}
==========

The presence of asymptomatic cases of COVID-19 was noted in early reports on the outbreak \[[@bib4],[@bib5]\] and a large study on 72 314 Chinese patients reported that 1% were asymptomatic \[[@bib6]\]. However, the majority of those cases were included from Hubei province, where the sudden shortage of health-care resources may have resulted in selection bias towards the exclusion of those with mild symptoms. Therefore, the actual prevalence of asymptomatic cases of COVID-19 could not be determined. We found that as much as one-fifth of individuals with COVID-19 had remained asymptomatic from potential exposure to laboratory confirmation and facility admission. Hence, our data fill an important gap concerning the prevalence of asymptomatic individuals, who constitute the base of the disease pyramid \[[@bib7]\]. Previous studies reported that viable SARS-CoV-2 was isolated from asymptomatic individuals and that certain groups of infections had been transmitted from asymptomatic patients \[[@bib8], [@bib9], [@bib10]\]; therefore, the notably high proportion of asymptomatic individuals in our data further supports the value of social distancing for the control of the current pandemic until a vaccine becomes available.

Separating individuals with suspected COVID-19 from other patients in outpatient clinics is critical for preventing a potential outbreak in the health-care setting. Therefore, it is important to delineate the epidemiological risk factors and clinical features of COVID-19. Furthermore, the pandemic spread of SARS-CoV-2 may weaken the role of epidemiological risk factors and clinical features of COVID-19 will become more important for screening. However, there are limited data on the symptoms of individuals with mild COVID-19. A recent Chinese study on 13 individuals with mild COVID-19 reported that nasal congestion (62%) was the most common symptom \[[@bib11]\]. In our 172 individuals, the most common symptom was cough, followed by hyposmia and sputum, while fever (\>37.5°C) was only observed in 11.6%.

Interestingly, hyposmia was quite frequent among individuals with mild COVID-19. Although hyposmia is caused by postviral olfactory dysfunction \[[@bib12]\], further studies are needed for the specificity of this symptom in COVID-19. In addition, pathophysiological studies are needed to determine whether this unique symptom is associated with nasal congestion, dysfunction of the olfactory nerve due to SARS-CoV-2, or other co-morbidities.

This study has several limitations. First, the study population shows a dominance of young age and female sex, which is largely due to the fact that most individuals were associated with a single religious group. Therefore, the results of this study may not be directly applicable to older populations or to males. Nevertheless, this is the largest study to date on the prevalence of asymptomatic patients and the detailed clinical symptoms in individuals with mild COVID-19. Second, the study design has inherent recall bias. However, the study participants were well educated and cooperative, so this bias may not have substantially affected our main findings. Third, we did not compare the symptoms of individuals with COVID-19 from those of patients with other respiratory viral infections, so further studies are needed on whether some dominant symptoms, such as hyposmia, are helpful to differentiate individuals with COVID-19 from those with other respiratory viral illnesses. Fourth, we did not perform other diagnostic tests to rule out the presence of co-infections. As a result, some of the symptoms presented in the study population might be associated with co-infections. A recent study reported that 20% of individuals with COVID-19 in northern California had one or more respiratory pathogens, including rhinovirus, respiratory syncytial virus, human coronavirus and influenza virus \[[@bib13]\]. Therefore, our findings on the symptoms of individuals with mild COVID-19 should be considered with caution. Finally, some selection bias may have been introduced in this survey-based study considering that approximately 18% of patients at the isolation facility did not participate in the study.

In conclusion, approximately one-fifth of individuals with mild COVID-19 were asymptomatic at admission and the most common symptoms of mild COVID-19 were cough with or without hyposmia and sputum. Further research on the contribution of asymptomatic or mildly symptomatic individuals to the community spread of COVID-19 is essential for effective control of the pandemic spread of SARS-CoV-2.
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The following is the Supplementary data to this article:Multimedia component 1Fig. S1: Relevance between hyposmia and hyposmia-associated symptoms (nasal congestion, hypogeusia and rhinorrhoea). Symptoms chart in patients with mild COVID-19 according to different time-points.Table S1: Prevalence of the symptoms in patients with mild COVID-19 according to different time points.Multimedia component 1
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[^2]: COVID-19, coronavirus disease 2019; IQR, interquartile range.

[^3]: Of 213 participating individuals, 41 asymptomatic individuals were excluded from the analysis.

[^4]: Among 68 individuals with hyposmia, 32 (47.1%) complained of having nasal congestion.
